|
[1] 孔繁鐘編譯, DSM-Ⅳ 精神疾病的診斷與統計. 合記圖書出版社 (1997) 80-90. [2] 孔繁鐘編譯, DSM-Ⅳ-TR 精神疾病診斷準則手冊修訂版. 合記圖書出版社 (2007) 59-64. [3] E. Bleuler, Dementia praecox oder Gruppe der Schizophrenien', In: G. Aschaffenburg (ed.). Handbuch der Psychiatrie. Spezieller Teil. 4. Abteilung, 1.H�纜fte. (1911). [4] L. Kanner, Autistic disturbances of affective contact. Nervous Child 2 (1943) 217-250. [5] S.L. Smalley, Genetic influences in childhood-onset psychiatric disorders: autism and attention-deficit/hyperactivity disorder. Am. J. Hum. Genet 60 (1997) 1276-1282. [6] A. Rett, Ueber ein eigenartiges hirnatrophisches Syndrom bei Hyperammoniamie in Kindesalter. Wien. Med. Wschr 116 (1966) 723-738. [7] T. Heller, Uber Dementia infantilis: Verbl�丼ungsproze�� im Kindesalter. Zeitschrift f�卣 die Erforschung und Behandlung des Jugendlichen Schwachsinns 2 (1908) 17–28. [8] H. Asperger, Die 'Autistischen Psychopathen' im Kindesalter. Archiv fur Psychiatrie und Nervenkrankheiten 117 (1944) 76-136. [9] E. Fombonne, Epidemiology of pervasive developmental disorders. Pediatric research 65 (2009) 591-598. [10] H.K.B. Blomquist, M.; Edvinsson, S. O.; Gillberg, C.; Gustavson, K.-H.; Holmgren, G.; Wahlstrom, J., Frequency of the fragile X syndrome in infantile autism: a Swedish multicenter study. Clin. Genet. 27 (1985) 113-117. [11] R.I. Tuchman R, Epilepsy in autism. Lancet Nerrology 1 (2002) 352-358. [12] V.F. Barton M, How commonly are known medical conditions associated with autism? J. Autism Dev. Disord 28 (1998) 273-278. [13] K.S. Chess S, B.P., Fernandez., Psychiatric disorders of children with congenital rubella. Brunner/ Mazel, Inc. (1971). [14] S.R. Folstein, M., Genetic influences and infantile autism. Nature 265 (1977) 726-728. [15] R.G. Benayed, N.; Rossman, I.; Mancuso, V.; Lazar, G.; Kamdar, S.; Bruse, S. E.; Tischfield, S.; Smith, B. J.; Zimmerman, R. A.; DiCicco-Bloom, E.; Brzustowicz, L. M.; Millonig, J. H. , Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus. Am. J. Hum. Genet. 77 (2005) 851-868. [16] L.B.M.-B. Jorde, A.; Waldmann, R.; Ritvo, E. R.; Freeman, B. J.; Pingree, C.; McMahon, W. M.; Petersen, B.; Jenson, W. R.; Mo, A., The UCLA--University of Utah epidemiologic survey of autism: genealogical analysis of familial aggregation. Am. J. Med. Genet 36 (1990) 85-88. [17] D.A.H. Greenberg, S. E.; Sowinski, J.; Nicoll, D., Excess of twins among affected sibling pairs with autism: implications for the etiology of autism. Am. J. Hum. Genet. 69 (2001) 1062-1067. [18] J.M.S. Silverman, C. J.; Schmeidler, J.; Hollander, E.; Lawlor, B. A.; Fitzgerald, M.; Buxbaum, J. D.; Delaney, K.; Galvin, P.; Autism Genetic Research Exchange Consortium, Symptom domains in autism and related conditions: evidence for familiality. Am. J. Med. Genet. (Neuropsychiat. Genet.) 114 (2002) 64-73. [19] A.L.C. Bailey, A.; Gottesman, I.; Bolton, P.; Simonoff, E.; Yuzda, E.; Rutter, M., Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med 25 (1995) 63-77. [20] H.F. Ronald A, Bolton P, Butcher LM, Price TS, Wheelwright S, Baron-Cohen S, Plomin R, Genetic heterogeneity between the three components of the autism spectrum: a twin study. J Am Acad Child Adolesc Psychiatry 45 (2006) 691-699. [21] S.M. Gupta AR, Autism Genetics. Rev. Bras. Psiquiatr 28 Suppl 1 (2006) S29-38. [22] I.M.G.S.o.A.C. (IMGSAC), A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet. 69 (2001) 570-581. [23] S.J. Campbell DB, Ebert PJ, Militerni R, Bravaccio C, Trillo S, Elia M, Schneider C, Melmed R, Sacco R, Persico AM, Levitt P, A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A. 103 (2006) 16834-16839. [24] D.O.R. Campbell DB, Garbett K, Ebert PJ, Mirnics K, Levitt P, Persico AM., Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol. 64 (2007) 243-250. [25] C.D. Arking DE, Brune CW, Teslovich TM, West K, Ikeda M, Rea A, Guy M, Lin S, Cook EH, Chakravarti A., A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet. 82 (2008) 160-164. [26] A.B. Alarc�曝 M, Stone JL, Duvall JA, Perederiy JV, Bomar JM, Sebat J, Wigler M, Martin CL, Ledbetter DH, Nelson SF, Cantor RM, Geschwind DH., Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet. 82 (2008) 150-159. [27] B.R. Gharani N, Mancuso V, Brzustowicz LM, Millonig JH., Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder. Mol Psychiatry. 9 (2004) 474-484. [28] G.N. Benayed R, Rossman I, Mancuso V, Lazar G, Kamdar S, Bruse SE, Tischfield S, Smith BJ, Zimmerman RA, Dicicco-Bloom E, Brzustowicz LM, Millonig JH., Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus. Am J Hum Genet. 77 (2005) 851-868. [29] S.I. Coutinho AM, Martins M, Correia C, Morgadinho T, Bento C, Marques C, Ata�櫃e A, Miguel TS, Moore JH, Oliveira G, Vicente AM., Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum Genet. 121 (2007) 243-256. [30] A.G.P. Consortium, Mapping autism risk loci using genetic linkage and chromosomal rearrangements. . Nature Genet. 39 (2007) 319-328. [31] J.L. Sebat, B.; Malhotra, D.; Troge, J.; Lese-Martin, C.; Walsh, T.; Yamrom, B.; Yoon, S.; Krasnitz, A.; Kendall, J.; Leotta, A.; Pai, D.; and 20 others Strong association of de novo copy number mutations with autism. Science 316 (2007) 445-449. [32] E.C.J. J Veenstra-VanderWeele, Molecular genetics of autism spectrum disorder. Molecular Psychiatry 9 (2004) 819-832. [33] C.R.N. Marshall, A.; Vincent, J. B.; Lionel, A. C.; Feuk, L.; Skaug, J.; Shago, M.; Moessner, R.; Pinto, D.; Ren, Y.; Thiruvahindrapduram, B.; Fiebig, A.; and 23 others Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet 82 (2008) 477-488. [34] S.Y. Weiss LA, Korn JM, Arking DE, Miller DT, Fossdal R, Saemundsen E, Stefansson H, Ferreira MA, Green T, Platt OS, Ruderfer DM, Walsh CA, Altshuler D, Chakravarti A, Tanzi RE, Stefansson K, Santangelo SL, Gusella JF, Sklar P, Wu BL, Daly MJ; Autism Consortium., Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med. 358 (2008) 667-675. [35] K.S. Kumar RA, Sudi J, Conrad DF, Brune C, Badner JA, Gilliam TC, Nowak NJ, Cook EH Jr, Dobyns WB, Christian SL., Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet. 17 (2008) 628-638. [36] C.S. Manning MA, Clericuzio C, Cherry AM, Schwartz S, Hudgins L, Enns GM, Hoyme HE., Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum. Pediatrics. 114 (2004) 451-457. [37] G.D. Abrahams BS, Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 9 (2008) 341-355. [38] G.R. Bonaglia MC, Mani E, Aceti G, Anderlid BM, Baroncini A, Pramparo T, Zuffardi O., Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome. J Med Genet. 43 (2005) 822-828. [39] B.C. Durand CM, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckars�鱸er H, Sponheim E, Goubran-Botros H, Delorme R, Chabane N, Mouren-Simeoni MC, de Mas P, Bieth E, Rog�� B, H�臆on D, Burglen L, Gillberg C, Leboyer M, Bourgeron T., Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet. 39 (2007) 25-27. [40] M.C. Moessner R, Sutcliffe JS, Skaug J, Pinto D, Vincent J, Zwaigenbaum L, Fernandez B, Roberts W, Szatmari P, Scherer SW., Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet. 81 (2007) 1289-1297. [41] C.S. Veenstra-Vanderweele J, Cook EH Jr., Autism as a paradigmatic complex genetic disorder. Annu Rev Genomics Hum Genet. 5 (2004) 379-405. [42] O.M. Kakinuma H, Sato H, Takahashi H., Variation in GABA-A subunit gene copy number in an autistic patient with mosaic 4 p duplication (p12p16). Am J Med Genet B Neuropsychiatr Genet. 147B (2008) 973-975. [43] A.D. Utine GE, Mosaicism for terminal deletion of 4q. 17 205-109 (2006). [44] T.B. Castermans D, Volders K, Crepel A, Vermeesch JR, Schrander-Stumpel CT, Van de Ven WJ, Steyaert JG, Creemers JW, Devriendt K., Position effect leading to haploinsufficiency in a mosaic ring chromosome 14 in a boy with autism. Eur J Hum Genet. 16 (2008) 1187-1192. [45] N.D. Havlovicova M, Kocarek E, Novotna K, Bendova S, Petrak B, Hrdlicka M, Sedlacek Z., A girl with neurofibromatosis type 1, atypical autism and mosaic ring chromosome 17. Am J Med Genet A. 143 (2007) 76-81. [46] Y.-C.J.C. Shuan-Yow Li, Te-Jen Lai, Chuan-Yu Hsu, Yi-Chun Wang, Molecular snd cytogenetic analyses of autism in Taiwan. Hum. Genet. 92 (1993) 441-445. [47] S.J. Matsuura T, Fang P, Galjaard RJ, Jiang YH, Benton CS, Rommens JM, Beaudet AL., De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet. 15 (1997) 74-77. [48] B.A. Peters SU, Madduri N, Bacino CA., Autism in Angelman syndrome: implications for autism research. Clin Genet. 66 (2004) 530-536. [49] L.V. Cook EH Jr, Leventhal BL, Courchesne R, Lincoln A, Shulman C, Lord C, Courchesne E., Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet. 60 (1997) 928-934.
|